CTSG inhibits HNSCC proliferation and metastasis in vivo and in vitro, which has the potential to be an oncogenic factor for HNSCC by focusing on the JAK2/STAT3 signaling pathway 47. This evidence concerns the gene CTSG and head and neck squamous cell carcinoma.